Kyle Noonan, PharmD
Health Outcomes and Market Access Fellow
AmerisourceBergen Xcenda

Can you give a brief overview of your functional area and its structure and value within your company?

Briefly, Health Outcomes centers around how a drug impacts patient outcomes, such as hospitalization or mortality. Market Access often uses these outcomes in addition to clinical data to tell the value story of a certain medication. Each of these takes many forms, but both are important aspects of the late development and commercialization phase of a drug, when speaking with a payer audience.

Within Xcenda, this places me under the Value and Access Strategy team.